SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 85 filers reported holding SAVARA INC in Q1 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $72 | -99.9% | 46,700 | 0.0% | 0.00% | – |
| Q3 2022 | $72,000 | -64.5% | 46,700 | -60.9% | 0.00% | -100.0% |
| Q2 2021 | $203,000 | -2.9% | 119,489 | +19.1% | 0.00% | 0.0% |
| Q1 2021 | $209,000 | -23.4% | 100,345 | -8.4% | 0.00% | -66.7% |
| Q2 2020 | $273,000 | +17.7% | 109,537 | +0.2% | 0.00% | 0.0% |
| Q1 2020 | $232,000 | +14.9% | 109,317 | +142.3% | 0.00% | +50.0% |
| Q4 2019 | $202,000 | +281.1% | 45,122 | +101.4% | 0.00% | +100.0% |
| Q2 2019 | $53,000 | -53.5% | 22,400 | +44.5% | 0.00% | -50.0% |
| Q1 2019 | $114,000 | -2.6% | 15,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $117,000 | – | 15,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |